{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:35:44Z","timestamp":1793716544043,"version":"4.6.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515013138"],"award-info":[{"award-number":["2024A1515013138"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["3240080489"],"award-info":[{"award-number":["3240080489"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.imbio.2026.153227","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T05:57:46Z","timestamp":1785995866000},"page":"153227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The CCL2-CCR2-Ly6c\u00a0+\u00a0macrophage axis in PegIFN\u03b1-2b therapy for chronic hepatitis B"],"prefix":"10.1016","volume":"231","author":[{"given":"Haiyi","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.imbio.2026.153227_bb0005","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/v16050724","article-title":"Hepatitis B Virus Infection: a Mini Review","volume":"16","author":"Asandem","year":"2024","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.imbio.2026.153227_bb0010","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.imbio.2026.153227_bb0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.gastro.2010.04.052","article-title":"Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers","volume":"139","author":"Brunetto","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.imbio.2026.153227_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaoncol.2018.4070","article-title":"Risk of Hepatocellular Carcinoma in patients Treated with Entecavir vs Tenofovir for Chronic Hepatitis B: a Korean Nationwide Cohort Study","volume":"5","author":"Choi","year":"2019","journal-title":"JAMA Oncol."},{"issue":"8","key":"10.1016\/j.imbio.2026.153227_bb0025","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153227_bb0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12985-024-02589-3","article-title":"Mechanisms underlying the compromised clinical efficacy of interferon in clearing HBV","volume":"21","author":"Lei","year":"2024","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.imbio.2026.153227_bb0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","article-title":"Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma","volume":"66","author":"Li","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.imbio.2026.153227_bb0040","article-title":"Transcriptomic Insights into Biomechanical Modulation of Gastrointestinal Function in a Rat Model of Functional Dyspepsia","volume":"23","author":"Liang","year":"2025","journal-title":"Iran. J. Biotechnol."},{"issue":"4","key":"10.1016\/j.imbio.2026.153227_bb0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41575-022-00724-5","article-title":"The scientific basis of combination therapy for chronic hepatitis B functional cure","volume":"20","author":"Lim","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.imbio.2026.153227_bb0050","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/jgh.12108","article-title":"Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice","volume":"28","author":"Lin","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.imbio.2026.153227_bb0055","article-title":"Study on the Retreatment, Outcome, and potential Predictors of Recurrence in patients with Recurrence of Hepatitis B after Functional Cure","volume":"13","author":"Lin","year":"2022","journal-title":"Front. Immunol."},{"issue":"44","key":"10.1016\/j.imbio.2026.153227_bb0060","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.3748\/wjg.v30.i44.4725","article-title":"Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens","volume":"30","author":"Lu","year":"2024","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.imbio.2026.153227_bb0065","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jhep.2021.05.013","article-title":"Covalently closed circular DNA: the ultimate therapeutic target for curing HBV infections","volume":"75","author":"Martinez","year":"2021","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.imbio.2026.153227_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2026.153227_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104815","article-title":"HBV replication inhibitors","volume":"179","author":"Pierra Rouviere","year":"2020","journal-title":"Antivir. Res."},{"issue":"11","key":"10.1016\/j.imbio.2026.153227_bb0080","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2026.153227_bb0085","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153227_bb0090","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1038\/s41467-023-43078-5","article-title":"Interferon stimulated immune profile changes in a humanized mouse model of HBV infection","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.imbio.2026.153227_bb0095","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","article-title":"How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?","volume":"76","author":"Wong","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.imbio.2026.153227_bb0100","doi-asserted-by":"crossref","first-page":"1017753","DOI":"10.3389\/fimmu.2022.1017753","article-title":"IFN\u03b1 subtype-specific susceptibility of HBV in the course of chronic infection","volume":"13","author":"Xie","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2026.153227_bb0105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2174\/0113892029387405250921211549","article-title":"Two-Stage Multi-View Graph Spectral Clustering for Single-Cell RNA-Seq Data","volume":"26","author":"Zhang","year":"2025","journal-title":"Curr. Genomics"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:53:02Z","timestamp":1793713982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298526000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0171298526000732"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153227","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The CCL2-CCR2-Ly6c\u00a0+\u00a0macrophage axis in PegIFN\u03b1-2b therapy for chronic hepatitis B","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153227"}}